Clinical Trials Directory

Trials / Completed

CompletedNCT01867580

A Pilot RCT of Veraflo With Prontosan vs VAC in Wounds Requiring Operative Debridement

A Prospective, Randomized, Multi-Center Trial Evaluating the Effectiveness of the V.A.C. Ulta Negative Pressure Wound Therapy System With V.A.C. VeraFlo Dressing System in Operatively Debrided Wounds

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
181 (actual)
Sponsor
KCI USA, Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the effectiveness of the Veraflo with Prontosan vs VAC in wounds that require operative debridement.

Conditions

Interventions

TypeNameDescription
DEVICEV.A.C.Ulta with Prontosan instillationNPWT with instillation of a wound cleanser (Prontosan® Wound Irrigation Solution)
DEVICEV.A.C.Ulta without instillationNPWT only

Timeline

Start date
2013-05-01
Primary completion
2015-08-01
Completion
2015-11-01
First posted
2013-06-04
Last updated
2024-12-02
Results posted
2017-11-29

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01867580. Inclusion in this directory is not an endorsement.

A Pilot RCT of Veraflo With Prontosan vs VAC in Wounds Requiring Operative Debridement (NCT01867580) · Clinical Trials Directory